EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   2.7.7.6 | Acidosis |
17102617 |
Restriction of rRNA synthesis by VHL maintains energy equilibrium under hypoxia. |
unassigned |
0 |
| 2.7.7.6 | Acidosis |
17942567 |
Maleate nephrotoxicity: mechanisms of injury and correlates with ischemic/hypoxic tubular cell death. |
unassigned |
0 |
| 2.7.7.6 | Acquired Immunodeficiency Syndrome |
22325276 |
A small post-translocation energy bias AIDS nucleotide selection in t7 RNA polymerase transcription. |
unassigned |
0 |
| 2.7.7.6 | Acquired Immunodeficiency Syndrome |
23066636 |
Transcription blockage by bulky end termini at single-strand breaks in the DNA template: differential effects of 5' and 3' adducts. |
therapeutic application
unassigned |
1
0 |
| 2.7.7.6 | Acquired Immunodeficiency Syndrome |
25690892 |
TEFM is a potent stimulator of mitochondrial transcription elongation in vitro. |
unassigned |
0 |
| 2.7.7.6 | Acute Kidney Injury |
18417719 |
Endotoxin mediates recruitment of RNA polymerase II to target genes in acute renal failure. |
causal interaction
ongoing research
unassigned |
2
1
0 |
| 2.7.7.6 | Acute Kidney Injury |
30140606 |
Atypical rapid onset Scleroderma Renal Crisis (SRC) complicated with diffuse alveolar hemorrhage and pleuro-pericardial effusions in a patient with recently diagnosed breast cancer and a positive anti-RNA polymerase III Ab.: A case report. |
causal interaction
unassigned |
3
0 |
| 2.7.7.6 | Adenocarcinoma |
8206980 |
Characterization of a protein that interacts with the rat ribosomal gene promoter and modulates RNA polymerase I transcription. |
ongoing research
unassigned |
2
0 |
| 2.7.7.6 | Adenocarcinoma |
27158556 |
Gender Specific Differences in RNA Polymerase III Transcription. |
causal interaction
diagnostic usage
ongoing research
unassigned |
3
1
3
0 |
| 2.7.7.6 | Adenocarcinoma |
34303658 |
AGR2-Dependent Nuclear Import of RNA Polymerase II Constitutes a Specific Target of Pancreatic Ductal Adenocarcinoma in the Context of Wild-Type p53. |
causal interaction
therapeutic application
unassigned |
4
2
0 |
